Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

NCT00104728 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
42
Enrollment
OTHER
Sponsor class

Stopped Early Stopping Rule: Would not meet interim analysis goal to proceed with enrollment

Conditions

Interventions

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators